Facebook
X
LinkedIn
Forward
Combatting Mycophenolate Risks in the Military Community: An Impactful Microlearning Approach to Strengthen the Delivery of REMS Compliant Care
This activity was based on the FDA Mycophenolate Risk Evaluation and Mitigation Strategy (REMS) Blueprint. Although the FDA discontinued the REMS requirement for mycophenolate products, the core tenets of the blueprint remain critical best practices for patient safety and standard of care
This Mycophenolate REMS-compliant activity was designed to educate healthcare providers about the management of female patients of reproductive potential who are prescribed mycophenolate — particularly those professionals who care/may care for active military members and Veterans. Female members of the Military Community are at a high risk for autoimmune disease and are likely to be prescribed mycophenolate during their child-bearing years. Studies have shown that women in the Military Community often do not receive risk-lowering care when prescribed teratogenic medications like mycophenolate. This microlearning activity provides comprehensive education on reducing the risk of embryofetal toxicity associated with the use of mycophenolate during pregnancy in eight 15-minute episodes. Each episode will be presented as a video, audio-only file, or monograph to allow the learner to create an optional learning experience that best aligns with their learning style.
Target Audience
The intended audience includes physicians, nurse practitioners, nurses, physician assistants, pharmacists and other providers involved in the management of female patients of reproductive potential who are prescribed mycophenolate.
Learning Objectives
After completing the educational activity, participants should be able to:
Identify the increased risks of first trimester pregnancy loss and congenital malformations associated with mycophenolate.
Develop strategies for educating females of reproductive potential about the risks of exposure to mycophenolate during pregnancy.
Plan the management of mycophenolate in females of reproductive potential.
Summarize provider responsibilities for reporting pregnancies to the Mycophenolate Pregnancy Registry and the importance of patient participation in the Mycophenolate Pregnancy Registry.
Commercial Support
There is no commerical support for this activity.
Course summary
- 2.00 AANP Contact Hours
Nurse Practitioners
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Veterans Health and Wellness Foundation (VHWF) and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is accredited by AANP as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 2.00 contact hour(s) (which includes 2.00 hour(s) of pharmacology).- 2.00 AANP Pharmacology Contact Hours
- 2.00 AAPA Category 1 CME
Physician Associates
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. - 2.00 ACPE Pharmacist
Pharmacists
AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 2.00 contact hours. - 2.00 AMA PRA Category 1 Credit™
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this Enduring Material for a maximum of 2.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. - 2.00 ANCC Contact Hours
Nurses
Credit being awarded: 2.00 ANCC contact hours - 2.00 AMA PRA Category 1 Credit™ Non-MD
Non-Physicians Seeking AMA Credit
AKH Inc., Advancing Knowledge in Healthcare designates this Enduring Material for a maximum of 2.00 AMA PRA Category 1 Credit(s)™.
Faculty & Planner Alicia Y. Christy MD, MHSCR (Chair) Evelyn Lewis, MD, MA, FAAFP, DABDA Jessica Lee Lin, MPAP Monica L Reynolds, MD, MSCR Stephanie Widmer, DO Dorothy Duffy, RPh Hailey Ehmke - Nurse Student Calla Ehmke - Patient Alexandra Poch - Patient Independent Reviewer Planners and Reviewers |
Disclosures
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare, Veterans Health and Wellness Foundation (VHWF) and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 2 Interprofessional Continuing Education (IPCE) credit for learning and change.
Available Credit
- 2.00 AANP Contact Hours
Nurse Practitioners
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Veterans Health and Wellness Foundation (VHWF) and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is accredited by AANP as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 2.00 contact hour(s) (which includes 2.00 hour(s) of pharmacology).- 2.00 AANP Pharmacology Contact Hours
- 2.00 AAPA Category 1 CME
Physician Associates
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. - 2.00 ACPE Pharmacist
Pharmacists
AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 2.00 contact hours. - 2.00 AMA PRA Category 1 Credit™
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this Enduring Material for a maximum of 2.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. - 2.00 ANCC Contact Hours
Nurses
Credit being awarded: 2.00 ANCC contact hours - 2.00 AMA PRA Category 1 Credit™ Non-MD
Non-Physicians Seeking AMA Credit
AKH Inc., Advancing Knowledge in Healthcare designates this Enduring Material for a maximum of 2.00 AMA PRA Category 1 Credit(s)™.
Price
Navigating the course:
To begin, select the first item under Course Progress to the left, then click Start.
Click Next to continue through the activity.
You can save and resume your progress at any time.
Criteria for Success:
To obtain a certificate of completion, a score of 70% or better on each of the post-tests is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-tests and evaluation, and have received a digital copy of your certificate. You must participate in the entire activity to receive credit.
Your online certificate will be saved on AKHCME within My Account > My Activities, which you can access at any time.
If you have questions about this activity, please contact AKH Inc. at [email protected].